MentionFox
Home › Grants › Anta Biotechnologies Corporation
Federal R&D award · SBIR Phase II

Anta Biotechnologies Corporation SBIR Phase II award

Award 2533096, starting 2025-09-15. Every figure below is from the federal award record.

National Science Foundation awarded Anta Biotechnologies Corporation of San Diego, CA $1,229,393 under the SBIR program (Phase II), with work starting 2025-09-15 and running to 2027-08-31. It is one of 2 SBIR and STTR awards Anta Biotechnologies Corporation received in the last two years, $1,403,892 in all. Each figure links to the federal record.

The award

RecipientAnta Biotechnologies Corporation (San Diego, CA)
Awarding agencyNational Science Foundation
PhasePhase II
Amount obligated$1,229,393
Period of performance starts2025-09-15
Period of performance ends2027-08-31
Award number2533096 (grant, CFDA 47.084)
Assistance listing47.084, Technology, Innovation, and Partnerships
Place of performanceSan Diego, San Diego County, CA
Signed2025-09-04
Recipient registry id (UEI)U1B4HRNRXEM9

Want the whole picture on Anta Biotechnologies Corporation?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Anta Biotechnologies Corporation: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Anta Biotechnologies Corporation covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

What it is for

Autonomous system for DNA sequencing prep in space and austere environments

Funding actions on this award

DateActionModificationAmount
2025-09-04New000$1,229,393
SBIR Phase II: Autonomous system for DNA sequencing prep in space and austere environments -the broader impact/commercial potential of this small business innovation research (SBIR) Phase II project is to build an automated, miniaturized, gravity-agnostic system for DNA extraction and preparation for sequencing in austere environments. DNA sequencing is used for a variety of purposes in research and medicine ? For example, diagnosis and treatment of diseases; monitoring of pathogens in water supplies and food; and to study the effects of various stressors on humans, crops, and even pets. The global DNA sequencing market size of $11B in 2022 is expected to grow to over $50B by 2032 indicating potential for growth and expansion of DNA sequencing technologies into untapped markets. This project is disrupting the market by developing a portable, automated system for extracting DNA from a variety of biosamples. Small academic and start-up labs and those focused on space research will be early market targets. This project expects to generate nearly $20M in revenue by year three of production. This small business innovation research (SBIR) Phase II project proposes to take a unique approach to technology development ? By building the technology for space and microgravity, the most extreme environment. Currently, there are no commercial automated, miniaturized technology exists for use ...

From the federal award record.

Other SBIR and STTR awards to Anta Biotechnologies Corporation

StartsAgencyProgramAmountProject
2025-09-29National Aeronautics and Space AdministrationSBIR$174,4991AUTOMATED DNA extraction in space (record)
Want the whole picture on Anta Biotechnologies Corporation?

Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.

Order Full Report on Anta Biotechnologies Corporation
Not ready to order?

Look up Anta Biotechnologies Corporation and see what is on record before you decide.

Get the free Snapshot

Where this comes from

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.

Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.

Cite this page

Permanent URL: https://mentionfox.com/grants/anta-biotechnologies-2533096
Last updated 2026-09-30
Primary record: Federal award record
Anta Biotechnologies Corporation: $1,229,393 SBIR Phase II award from the NSF (2025). MentionFox, 2026-09-30. https://mentionfox.com/grants/anta-biotechnologies-2533096